Dr. Reddy’s Labs, Slayback sign licensing deal for Brimonidine Tartrate
Dr. Reddy’s Laboratories said that it has signed a licensing deal with New Jersey-based Slayback Pharma for acquiring rights in the latter’s Brimonidine Tartrate Ophthalmic Solution 0.025%. Brimonidine Tartrate Ophthalmic Solution 0.025% is the private label equivalent of Lumify in the US. Lumify, which is an over-the-counter (OTC) eyedrop, can be used for easing the […]